Literature DB >> 21674433

A quarter century of pharmacognostic research on Panamanian flora: a review.

Catherina Caballero-George1, Mahabir P Gupta.   

Abstract

Panama is a unique terrestrial bridge of extreme biological importance. It is one of the "hot spots" and occupies the fourth place among the 25 most plant-rich countries in the world, with 13.4 % endemic species. Panamanian plants have been screened for a wide range of biological activities: as cytotoxic, brine shrimp-toxic, antiplasmodial, antimicrobial, antiviral, antioxidant, immunosuppressive, and antihypertensive agents. This review concentrates on ethnopharmacological uses of medicinal plants employed by three Amerindian groups of Panama and on selected plants with novel structures and/or interesting bioactive compounds. During the last quarter century, a total of approximately 390 compounds from 86 plants have been isolated, of which 160 are new to the literature. Most of the work reported here has been the result of many international collaborative efforts with scientists worldwide. From the results presented, it is immediately obvious that the Panamanian flora is still an untapped source of new bioactive compounds. © Georg Thieme Verlag KG Stuttgart · New York.

Mesh:

Substances:

Year:  2011        PMID: 21674433     DOI: 10.1055/s-0030-1271187

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

1.  Cheminformatic characterization of natural products from Panama.

Authors:  Dionisio A Olmedo; Mariana González-Medina; Mahabir P Gupta; José L Medina-Franco
Journal:  Mol Divers       Date:  2017-08-22       Impact factor: 2.943

Review 2.  Xylosma G. Forst. Genus: Medicinal and Veterinary Use, Phytochemical Composition, and Biological Activity.

Authors:  Rodrigo Duarte-Casar; Juan Carlos Romero-Benavides
Journal:  Plants (Basel)       Date:  2022-05-05

3.  Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.

Authors:  Armando Herrera-Arellano; Edgar O López-Villegas; Aida V Rodríguez-Tovar; Alejandro Zamilpa; Enrique Jiménez-Ferrer; Jaime Tortoriello; M Angeles Martínez-Rivera
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

4.  Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk.

Authors:  Michael Heinrich; Francesca Scotti; Adolfo Andrade-Cetto; Monica Berger-Gonzalez; Javier Echeverría; Fabio Friso; Felipe Garcia-Cardona; Alan Hesketh; Martin Hitziger; Caroline Maake; Matteo Politi; Carmenza Spadafora; Rita Spadafora
Journal:  Front Pharmacol       Date:  2020-06-08       Impact factor: 5.810

5.  Antioxidant and anti-dermatophytic properties leaf and stem bark of Xylosma longifolium clos.

Authors:  Wangkheirakpam Radhapiyari Devi; S Brojendro Singh; Chingakham B Singh
Journal:  BMC Complement Altern Med       Date:  2013-07-02       Impact factor: 3.659

6.  Screening of Panamanian Plant Extracts for Pesticidal Properties and HPLC-Based Identification of Active Compounds.

Authors:  Niels Guldbrandsen; Maria De Mieri; Mahabir Gupta; Tobias Seiser; Christine Wiebe; Joachim Dickhaut; Rüdiger Reingruber; Oliver Sorgenfrei; Matthias Hamburger
Journal:  Sci Pharm       Date:  2014-12-11

7.  Screening of Panamanian Plants for Cosmetic Properties, and HPLC-Based Identification of Constituents with Antioxidant and UV-B Protecting Activities.

Authors:  Niels Guldbrandsen; Maria De Mieri; Mahabir Gupta; Eleni Liakou; Harris Pratsinis; Dimitris Kletsas; Eliza Chaita; Nektarios Aligiannis; Alexios-Leandros Skaltsounis; Matthias Hamburger
Journal:  Sci Pharm       Date:  2014-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.